BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38616927)

  • 1. Cardiovascular Risk Factors Among First-Degree Relatives of Patients with Premature Cardiovascular Disease in Malta. Baseline Findings from the CRISO Project.
    Mifsud JL; Galea J
    Vasc Health Risk Manag; 2024; 20():167-176. PubMed ID: 38616927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease: the CRISO study protocol for a randomised controlled pilot study.
    Mifsud JL; Stephenson J; Astin F; Galea J
    Pilot Feasibility Stud; 2021 Aug; 7(1):153. PubMed ID: 34372930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus-a multicenter study in China.
    Zheng J; Hu Y; Xu H; Lei Y; Zhang J; Zheng Q; Li L; Tu W; Chen R; Guo Q; Zang X; You Q; Xu Z; Zhou Q; Wu X
    Cardiovasc Diabetol; 2023 Jun; 22(1):137. PubMed ID: 37308932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental cardiovascular disease and cardiovascular disease risk factors in the offspring: The Diet, Cancer and Health cohorts.
    Petersen KE; Rosthøj S; Halkjær J; Loft S; Tjønneland A; Olsen A
    Atherosclerosis; 2024 Jan; 388():117406. PubMed ID: 38141480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrition Intervention for Reduction of Cardiovascular Risk in African Americans Using the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines.
    Williams KA; Fughhi I; Fugar S; Mazur M; Gates S; Sawyer S; Patel H; Chambers D; McDaniel R; Reiser JR; Mason T
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in predictors of incident heart failure according to atherosclerotic cardiovascular disease status.
    Dawson LP; Carrington MJ; Haregu T; Nanayakkara S; Jennings G; Dart A; Stub D; Kaye D
    ESC Heart Fail; 2023 Dec; 10(6):3398-3409. PubMed ID: 37688465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of novel low-density lipoprotein-cholesterol calculation methods in predicting clinical and subclinical atherosclerotic cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis.
    Cao J; Remaley AT; Guan W; Devaraj S; Tsai MY
    Atherosclerosis; 2021 Jun; 327():1-4. PubMed ID: 34004482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F
    J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study.
    Florido R; Zhao D; Ndumele CE; Lutsey PL; McEvoy JW; Windham BG; Pankow JS; Guallar E; Michos ED
    J Am Heart Assoc; 2016 Aug; 5(9):. PubMed ID: 27577582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk profiles in patients with inflammatory bowel disease differ from matched controls from the general population.
    Sleutjes JAM; van der Woude CJ; Verploegh PJP; Aribas E; Kavousi M; Roeters van Lennep JE; de Vries AC
    Eur J Prev Cardiol; 2023 Oct; 30(15):1615-1622. PubMed ID: 37075221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between low-density and non-high-density lipoprotein cholesterol with incident cardiovascular disease among low-risk Iranians during 2 decades follow-up.
    Tohidi M; Asgari S; Chary A; Azizi F; Hadaegh F
    Clin Biochem; 2022; 109-110():28-36. PubMed ID: 35970222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Gooding HC; Ning H; Gillman MW; Shay C; Allen N; Goff DC; Lloyd-Jones D; Chiuve S
    JAMA Intern Med; 2017 Sep; 177(9):1354-1360. PubMed ID: 28715555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.
    Wong ND; Budoff MJ; Ferdinand K; Graham IM; Michos ED; Reddy T; Shapiro MD; Toth PP
    Am J Prev Cardiol; 2022 Jun; 10():100335. PubMed ID: 35342890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study.
    Jain V; Rifai MA; Brinzevich D; Taj M; Saleh M; Krittanawong C; Patel J; Patel A; Lee MT; Mahtta D; Virani SS
    Eur J Prev Cardiol; 2022 Mar; 29(3):493-501. PubMed ID: 34059910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Atherosclerotic Cardiovascular Risk Factors and Cardiometabolic Profiles Between Current and Never Users of Marijuana.
    Alhassan HA; Akunor H; Howard A; Donohue J; Kainat A; Onyeaka HK; Aiyer A
    Circ Cardiovasc Qual Outcomes; 2023 Nov; 16(11):e009609. PubMed ID: 37860878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys.
    Patel KK; Taksler GB; Hu B; Rothberg MB
    Ann Intern Med; 2017 Jun; 166(12):876-882. PubMed ID: 28505660
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.